MedTrace Logo

Neurofeedback for Borderline Personality Disorder

NCT05398627 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2026-05-05

No results posted yet for this study

Summary

The goal of this study is to evaluate whether rtfMRI-nf training to increase the amygdala response to positive memories may serve as an intervention for borderline personality disorder.

Conditions

  • Borderline Personality Disorder

Interventions

DEVICE

Amygdala Neurofeedback

real-time feedback on the hemodynamic response of the amygdala during positive autobiographical memory recall

Sponsors & Collaborators

  • AE Foundation

    collaborator OTHER

  • Kymberly Young

    lead OTHER

Principal Investigators

  • Kymberl Young, PhD · University of Pittsburgh

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
55 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-09-02
Primary Completion
2026-04-30
Completion
2026-04-30
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05398627 on ClinicalTrials.gov